Figure 1From: Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and BelgiumMean Clinical Global Impressions—Severity (CGI-S) scores by visit and country for patients who had 24 months of treatment. All changes from baseline, P < 0.001, paired t test. BL = baseline.Back to article page